SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 (Q107344282)

45

object named as

Kenneth A Stapleford

0 references

Maudry Laurent-Rolle

5

object named as

Maudry Laurent-Rolle

0 references

author name string

Qiao Lu

1

0 references

Jia Liu

2

0 references

Shuai Zhao

3

0 references

Maria Florencia Gomez Castro

4

0 references

Jianbo Dong

6

0 references

Xiaojuan Ran

7

0 references

Payal Damani-Yokota

8

0 references

Hongzhen Tang

9

0 references

Triantafyllia Karakousi

10

0 references

Juhee Son

11

0 references

Maria E Kaczmarek

12

0 references

Ze Zhang

13

0 references

Stephen T Yeung

14

0 references

Broc T McCune

15

0 references

Rita E Chen

16

0 references

Fei Tang

17

0 references

Xianwen Ren

18

0 references

Xufeng Chen

19

0 references

Jack C C Hsu

20

0 references

Marianna Teplova

21

0 references

Betty Huang

22

0 references

Haijing Deng

23

0 references

Zhilin Long

24

0 references

Tenny Mudianto

25

0 references

Shumin Jin

26

0 references

Peng Lin

27

0 references

Jasper Du

28

0 references

Ruochen Zang

29

0 references

Tina Tianjiao Su

30

0 references

Alberto Herrera

31

0 references

Ming Zhou

32

0 references

Renhong Yan

33

0 references

Jia Cui

34

0 references

James Zhu

35

0 references

Qiang Zhou

36

0 references

Tao Wang

37

0 references

Jianzhu Ma

38

0 references

Sergei B Koralov

39

0 references

Zemin Zhang

40

0 references

Leopoldo N Segal

42

0 references

Michael S Diamond

43

0 references

Kamal M Khanna

44

0 references

Peter Cresswell

46

0 references

Yue Liu

47

0 references

Siyuan Ding

48

0 references

Qi Xie

49

0 references

Jun Wang

full work available at URL

50

0 references

language of work or name

English

0 references

publication date

8 June 2021

0 references

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106883

0 references

published in

Immunity

0 references

volume

54

0 references

issue

6

0 references

page(s)

1304-1319.e9

0 references

describes a project that uses

Cytoscape

1 reference

Europe PubMed Central

9 June 2022

https://europepmc.org/search?query=(METHODS:'Cytoscape')

based on heuristic

inferred from PubMed Central ID database lookup

cites work

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

CLEC5A is critical for dengue-virus-induced lethal disease

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Neuropilin-1 is a host factor for SARS-CoV-2 infection

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Measles virus targets DC-SIGN to enhance dendritic cell infection

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Compassionate Use of Remdesivir for Patients with Severe Covid-19

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

CLEC10A Is a Specific Marker for Human CD1c Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Binding of DC-SIGN to the hemagglutinin of influenza A viruses supports virus replication in DC-SIGN expressing cells.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Human neutralizing antibodies elicited by SARS-CoV-2 infection

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Clec10a regulates mite-induced dermatitis

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Human dendritic cell DC-SIGN and TLR-2 mediate complementary immune regulatory activities in response to Lactobacillus rhamnosus JB-1.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Fast gapped-read alignment with Bowtie 2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

N-Linked Glycosylation Facilitates Sialic Acid-Independent Attachment and Entry of Influenza A Viruses into Cells Expressing DC-SIGN or L-SIGN

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A novel probe to assess cytosolic entry of exogenous proteins

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Yeast surface display platform for rapid discovery of conformationally selective nanobodies.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Cytokine release syndrome in severe COVID-19

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Immunopathogenesis of coronavirus infections: implications for SARS.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Structural basis of receptor recognition by SARS-CoV-2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Cytoscape: a software environment for integrated models of biomolecular interaction networks

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Lentivirus-delivered stable gene silencing by RNAi in primary cells

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A novel human Cl(-) channel family related to Drosophila flightless locus

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

C-type lectin DC-SIGN: an adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Liver sinusoidal endothelial cell lectin, LSECtin, negatively regulates hepatic T-cell immune response

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Optimizing hydrolysis of N-linked high-mannose oligosaccharides by endo-beta-N-acetylglucosaminidase H

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Immunology of COVID-19: Current State of the Science

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Site-specific glycan analysis of the SARS-CoV-2 spike

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

SCANPY: large-scale single-cell gene expression data analysis.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A new coronavirus associated with human respiratory disease in China

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

An Infectious cDNA Clone of SARS-CoV-2

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Asialoglycoprotein receptor facilitates infection of PLC/PRF/5 cells by HEV through interaction with ORF2.

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

The Myeloid LSECtin Is a DAP12-Coupled Receptor That Is Crucial for Inflammatory Response Induced by Ebola Virus Glycoprotein

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

A pneumonia outbreak associated with a new coronavirus of probable bat origin

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006

Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study

25 June 2021

1 reference

https://api.crossref.org/works/10.1016/J.IMMUNI.2021.05.006